医药导报
醫藥導報
의약도보
HERALD OF MEDICINE
2015年
7期
903-906
,共4页
帕罗西汀,盐酸%结肠炎,溃疡性%焦虑%抑郁%老年患者
帕囉西汀,鹽痠%結腸炎,潰瘍性%焦慮%抑鬱%老年患者
파라서정,염산%결장염,궤양성%초필%억욱%노년환자
Paroxetine,hydrochloride%Colitis,ulcerative%Anxiety%Depression%Elderly patients
目的:观察盐酸帕罗西汀辅助治疗老年溃疡性结肠炎( UC)伴焦虑/抑郁的疗效。方法将80例老年UC伴焦虑/抑郁患者采用随机数字表法随机分为治疗组及对照组各40例,对照组轻度UC患者给予美沙拉嗪肠溶片1 g, tid,po;中度UC患者给予美沙拉嗪肠溶片1 g,qid,po。足量治疗2周效果较差者加用醋酸泼尼松片10 mg,qid,po;治疗组在对照组基础上加用盐酸帕罗西汀片,起始10 mg·d-1,3 d后增加至20 mg·d-1,疗程2个月。治疗期间禁饮酒、咖啡及辛辣刺激性食物;每2周复诊1次。治疗前后对每例患者行UC临床及肠镜表现Mayo综合评分、汉密尔顿焦虑/抑郁( HAMA/HAMD)评分测试,比较治疗后的改善情况。结果治疗组治疗后Mayo综合评分较对照组显著下降,改善总有效率明显高于对照组(P<0.05);治疗组治疗后HAMA、HAMD评分均较对照组明显降低(均P<0.01)。结论帕罗西汀辅助治疗老年UC伴焦虑/抑郁,临床和肠镜综合表现以及焦虑/抑郁均有明显改善。
目的:觀察鹽痠帕囉西汀輔助治療老年潰瘍性結腸炎( UC)伴焦慮/抑鬱的療效。方法將80例老年UC伴焦慮/抑鬱患者採用隨機數字錶法隨機分為治療組及對照組各40例,對照組輕度UC患者給予美沙拉嗪腸溶片1 g, tid,po;中度UC患者給予美沙拉嗪腸溶片1 g,qid,po。足量治療2週效果較差者加用醋痠潑尼鬆片10 mg,qid,po;治療組在對照組基礎上加用鹽痠帕囉西汀片,起始10 mg·d-1,3 d後增加至20 mg·d-1,療程2箇月。治療期間禁飲酒、咖啡及辛辣刺激性食物;每2週複診1次。治療前後對每例患者行UC臨床及腸鏡錶現Mayo綜閤評分、漢密爾頓焦慮/抑鬱( HAMA/HAMD)評分測試,比較治療後的改善情況。結果治療組治療後Mayo綜閤評分較對照組顯著下降,改善總有效率明顯高于對照組(P<0.05);治療組治療後HAMA、HAMD評分均較對照組明顯降低(均P<0.01)。結論帕囉西汀輔助治療老年UC伴焦慮/抑鬱,臨床和腸鏡綜閤錶現以及焦慮/抑鬱均有明顯改善。
목적:관찰염산파라서정보조치료노년궤양성결장염( UC)반초필/억욱적료효。방법장80례노년UC반초필/억욱환자채용수궤수자표법수궤분위치료조급대조조각40례,대조조경도UC환자급여미사랍진장용편1 g, tid,po;중도UC환자급여미사랍진장용편1 g,qid,po。족량치료2주효과교차자가용작산발니송편10 mg,qid,po;치료조재대조조기출상가용염산파라서정편,기시10 mg·d-1,3 d후증가지20 mg·d-1,료정2개월。치료기간금음주、가배급신랄자격성식물;매2주복진1차。치료전후대매례환자행UC림상급장경표현Mayo종합평분、한밀이돈초필/억욱( HAMA/HAMD)평분측시,비교치료후적개선정황。결과치료조치료후Mayo종합평분교대조조현저하강,개선총유효솔명현고우대조조(P<0.05);치료조치료후HAMA、HAMD평분균교대조조명현강저(균P<0.01)。결론파라서정보조치료노년UC반초필/억욱,림상화장경종합표현이급초필/억욱균유명현개선。
Objective To investigate the efficacy of paroxetine hydrochloride on elderly ulcerative colitis with anxiety /depression as adjuvant treatment. Methods The total of 80 cases of elderly ulcerative colitis with anxiety / depression were randomly assigned to the treatment and control groups ( n= 40 cases) . The mild or moderate UC patients in the control group were treated with mesalazine enteric coated tablets 1 g,tid,po or 1 g,qid,po, respectively;upon the complete treatment for 2 weeks, the patients with lower response were added with prednisone acetate tablets 10 mg,qid,po;and the patients in the treatment group were treated with paroxetine hydrochloride tablets starting from 10 mg·d-1 to 20 mg·d-1 3 days later, for 2 months in addition to the basic treatment as those in the control group. No alcohol, no coffee and no irritated foods were allowed during the treatment;regular reexamination was taken once for every 2 weeks. The clinical manifestations and colonoscopy Mayo composite score and Hamilton anxiety / depression ( HAMA/HAMD) score test were assessed for every patient before and after treatment, to detect the improvement after treatment. Results After treatment, the Mayo scores of the treatment group decreased significantly in comparison to the control group,with the total efficiency was markedly higher than that of the control group ( P<0. 05);HAMA and HAMD in treatment group were obviously lower than those before treatment ( both P<0. 01);HAMA and HAMD scores in the control group displayed no variation after treatment. Conclusion The adjuvant therapy of paroxetine hydrochloride remarkably improves the clinical and endoscopic manifestations of elderly patients with ulcerative colitis with anxiety/depression.